Resolution of spontaneous hemoabdomen secondary to peliosis hepatis following surgery and azithromycin treatment in a <i>Bartonella</i> species infected dog

Berkowitz, Steven T.; Gannon, Kristi; Carberry, Carol A.; Cortes, Yonaira

doi:10.1111/vec.12479

Cited by 9 publications

(5 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Spain, B. henselae and B. vinsonii berkhoffii seroprevalences were 16.8 and 1.1%, respectively [ 74 ]. Moreover, it is important to remark that after a search in PubMed we found around seven times more reports of Bartonella infection in dogs in the USA than in Europe [ 5 , 14 , 28 – 31 , 38 , 75 – 100 ]. Information regarding clinico-epidemiological studies performed in dogs in other continents is summarized in Table 5 .…”

Section: Epidemiology Prevalence and Distribution In Europementioning

confidence: 99%

Bartonella infections in cats and dogs including zoonotic aspects

2018

View full text Add to dashboard Cite

Bartonellosis is a vector-borne zoonotic disease with worldwide distribution that can infect humans and a large number of mammals including small companion animals (cats and dogs). In recent years, an increasing number of studies from around the world have reported Bartonella infections, although publications have predominantly focused on the North American perspective. Currently, clinico-pathological data from Europe are more limited, suggesting that bartonellosis may be an infrequent or underdiagnosed infectious disease in cats and dogs. Research is needed to confirm or exclude Bartonella infection as a cause of a spectrum of feline and canine diseases. Bartonella spp. can cause acute or chronic infections in cats, dogs and humans. On a comparative medical basis, different clinical manifestations, such as periods of intermittent fever, granulomatous inflammation involving the heart, liver, lymph nodes and other tissues, endocarditis, bacillary angiomatosis, peliosis hepatis, uveitis and vasoproliferative tumors have been reported in cats, dogs and humans. The purpose of this review is to provide an update and European perspective on Bartonella infections in cats and dogs, including clinical, diagnostic, epidemiological, pathological, treatment and zoonotic aspects.

show abstract

Section: Epidemiology Prevalence and Distribution In Europementioning

confidence: 99%

Bartonella infections in cats and dogs including zoonotic aspects

2018

View full text Add to dashboard Cite

show abstract

“…azithromycin/minocycline) (e.g. [175–181]. As the pathogens possess a zoonotic potential, prevention of pathogen transmission is essential especially in form of ectoparasite control.…”

Section: Bacterial Diseasesmentioning

confidence: 99%

A review on the occurrence of companion vector-borne diseases in pet animals in Latin America

2019

View full text Add to dashboard Cite

Companion vector-borne diseases (CVBDs) are an important threat for pet life, but may also have an impact on human health, due to their often zoonotic character. The importance and awareness of CVBDs continuously increased during the last years. However, information on their occurrence is often limited in several parts of the world, which are often especially affected. Latin America (LATAM), a region with large biodiversity, is one of these regions, where information on CVBDs for pet owners, veterinarians, medical doctors and health workers is often obsolete, limited or non-existent. In the present review, a comprehensive literature search for CVBDs in companion animals (dogs and cats) was performed for several countries in Central America (Belize, Caribbean Islands, Costa Rica, Cuba, Dominican Republic, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Puerto Rico) as well as in South America (Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana (British Guyana), Paraguay, Peru, Suriname, Uruguay, Venezuela) regarding the occurrence of the following parasitic and bacterial diseases: babesiosis, heartworm disease, subcutaneous dirofilariosis, hepatozoonosis, leishmaniosis, trypanosomosis, anaplasmosis, bartonellosis, borreliosis, ehrlichiosis, mycoplasmosis and rickettsiosis. An overview on the specific diseases, followed by a short summary on their occurrence per country is given. Additionally, a tabular listing on positive or non-reported occurrence is presented. None of the countries is completely free from CVBDs. The data presented in the review confirm a wide distribution of the CVBDs in focus in LATAM. This wide occurrence and the fact that most of the CVBDs can have a quite severe clinical outcome and their diagnostic as well as therapeutic options in the region are often difficult to access and to afford, demands a strong call for the prevention of pathogen transmission by the use of ectoparasiticidal and anti-feeding products as well as by performing behavioural changes.

show abstract

“…cause the non-neoplastic endothelial proliferative disorders bacillary angiomatosis and peliosis hepatis in humans, and there have also been rare reports of these conditions in dogs infected with Bartonella spp. [26][27][28][29][30][31]53,55,56] In addition, there have been case reports documenting neoplastic endothelial cell tumors in humans and dogs infected with Bartonella spp. : B. vinsonii subsp.…”

Section: Discussionmentioning

confidence: 99%

“…can cause endothelial proliferative disorders, including bacillary angiomatosis and peliosis hepatis, in dogs and humans. [26][27][28][29][30][31] In combination, these observations suggest the potential for involvement of intra-erythrocytic and endotheliotropic Bartonella spp. in the initiation and/or progression of vascular endothelial neoplasia in dogs.…”

Section: Introductionmentioning

confidence: 87%

Molecular prevalence of Bartonella, Babesia, and hemotropic Mycoplasma species in dogs with hemangiosarcoma from across the United States

et al. 2020

View full text Add to dashboard Cite

Hemangiosarcoma (HSA), a locally invasive and highly metastatic endothelial cell neoplasm, accounts for two-thirds of all cardiac and splenic neoplasms in dogs. Bartonella spp. infection has been reported in association with neoplastic and non-neoplastic vasoproliferative lesions in animals and humans. The objective of this study was to determine the prevalence of Bartonella spp. in conjunction with two other hemotropic pathogens, Babesia spp. and hemotropic Mycoplasma spp., in tissues and blood samples from 110 dogs with histopathologically diagnosed HSA from throughout the United States. This was a retrospective, observational study using clinical specimens from 110 dogs with HSA banked by the biospecimen repository of the Canine Comparative Oncology and Genomics Consortium. Samples provided for this study from each dog included: fresh frozen HSA tumor tissue (available from n = 100 of the 110 dogs), fresh frozen non-tumor tissue (n = 104), and whole blood and serum samples (n = 108 and 107 respectively). Blood and tissues were tested by qPCR for Bartonella, hemotropic Mycoplasma, and Babesia spp. DNA; serum was tested for Bartonella spp. antibodies. Bartonella spp. DNA was amplified and sequenced from 73% of dogs with HSA (80/110). In contrast, hemotropic Mycoplasma spp. DNA was amplified from a significantly smaller proportion (5%, p<0.0001) and Babesia spp. DNA was not amplified from any dog. Of the 100 HSA tumor samples submitted, 34% were Bartonella PCR positive (32% of splenic tumors, 57% of cardiac tumors, and 17% of other tumor locations). Of 104 non-tumor tissues, 63% were Bartonella PCR positive (56% of spleen samples, 93% of cardiac samples, and 63% of skin/subcutaneous samples). Of dogs with Bartonella positive HSA tumor, 76% were also positive in non-tumor tissue. Bartonella spp. DNA was not PCR amplified from whole blood. This study documented a high prevalence of Bartonella spp. DNA in dogs with HSA from geographically diverse regions of the United States. While 73%

show abstract

Resolution of spontaneous hemoabdomen secondary to peliosis hepatis following surgery and azithromycin treatment in a Bartonella species infected dog

Abstract: This is the first reported case of PH and hemoperitoneum in a Bartonella species serology positive dog wherein treatment with azithromycin resulted in serology negative status. There have been no subsequent episodes of hemoperitoneum in the 12 months since treatment.

Cited by 9 publications

References 25 publications

Bartonella infections in cats and dogs including zoonotic aspects

Bartonella infections in cats and dogs including zoonotic aspects

A review on the occurrence of companion vector-borne diseases in pet animals in Latin America

Molecular prevalence of Bartonella, Babesia, and hemotropic Mycoplasma species in dogs with hemangiosarcoma from across the United States

Contact Info

Product

Resources

About